453 related articles for article (PubMed ID: 7480160)
1. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms.
Beavo JA
Physiol Rev; 1995 Oct; 75(4):725-48. PubMed ID: 7480160
[TBL] [Abstract][Full Text] [Related]
2. Cyclic-3',5'-nucleotide phosphodiesterase isozymes in cell biology and pathophysiology of the kidney.
Dousa TP
Kidney Int; 1999 Jan; 55(1):29-62. PubMed ID: 9893113
[TBL] [Abstract][Full Text] [Related]
3. Phosphodiesterases in the vascular system.
Matsumoto T; Kobayashi T; Kamata K
J Smooth Muscle Res; 2003 Aug; 39(4):67-86. PubMed ID: 14692693
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1.
Murray F; Patel HH; Suda RY; Zhang S; Thistlethwaite PA; Yuan JX; Insel PA
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L294-303. PubMed ID: 16980375
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
6. Isolation, expression and analysis of splice variants of a human Ca2+/calmodulin-stimulated phosphodiesterase (PDE1A).
Snyder PB; Florio VA; Ferguson K; Loughney K
Cell Signal; 1999 Jul; 11(7):535-44. PubMed ID: 10405764
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases: gene complexity, regulation by phosphorylation, and physiological implications.
Burns F; Zhao AZ; Beavo JA
Adv Pharmacol; 1996; 36():29-48. PubMed ID: 8783553
[No Abstract] [Full Text] [Related]
8. The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner.
Yan C; Zhao AZ; Bentley JK; Beavo JA
J Biol Chem; 1996 Oct; 271(41):25699-706. PubMed ID: 8810348
[TBL] [Abstract][Full Text] [Related]
9. Intracellular targeting, interaction with Src homology 3 (SH3) domains and rolipram-detected conformational switches in cAMP-specific PDE4A phosphodiesterase.
Houslay MD; Scotland G; Erdogan S; Huston E; Mackenzie S; McCallum JF; McPhee I; Pooley L; Rena G; Ross A; Beard M; Peder A; Begg F; Wilkinson I; Yarwood S; Ackerman C; Houslay ES; Hoffman R; Engels P; Sullivan M; Bolger G
Biochem Soc Trans; 1997 May; 25(2):374-81. PubMed ID: 9191121
[No Abstract] [Full Text] [Related]
10. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
Zhou L; Thompson WJ; Potter DE
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1745-52. PubMed ID: 10393044
[TBL] [Abstract][Full Text] [Related]
11. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families.
Manganiello VC; Murata T; Taira M; Belfrage P; Degerman E
Arch Biochem Biophys; 1995 Sep; 322(1):1-13. PubMed ID: 7574662
[No Abstract] [Full Text] [Related]
12. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.
de Vente J; Markerink-van Ittersum M; Vles JS
J Chem Neuroanat; 2006 Jun; 31(4):275-303. PubMed ID: 16621445
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase inhibitors in airways disease.
Fan Chung K
Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
[TBL] [Abstract][Full Text] [Related]
14. Elevated cAMP-phosphodiesterase in atopic disease: cause or effect?
Townley RG
J Lab Clin Med; 1993 Jan; 121(1):15-7. PubMed ID: 8381147
[No Abstract] [Full Text] [Related]
15. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of phosphodiesterase in Drosophila.
Davis RL
Methods Enzymol; 1988; 159():786-92. PubMed ID: 2842643
[No Abstract] [Full Text] [Related]
17. Identification of inhibitory and calmodulin-binding domains of the PDE1A1 and PDE1A2 calmodulin-stimulated cyclic nucleotide phosphodiesterases.
Sonnenburg WK; Seger D; Kwak KS; Huang J; Charbonneau H; Beavo JA
J Biol Chem; 1995 Dec; 270(52):30989-1000. PubMed ID: 8537356
[TBL] [Abstract][Full Text] [Related]
18. Expression of human recombinant cAMP phosphodiesterase isozyme IV reverses growth arrest phenotypes in phosphodiesterase-deficient yeast.
McHale MM; Cieslinski LB; Eng WK; Johnson RK; Torphy TJ; Livi GP
Mol Pharmacol; 1991 Feb; 39(2):109-13. PubMed ID: 1847489
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
20. [Cyclic nucleotide phosphodiesterases: diversity, classification, structure and function].
Rascón A
Acta Cient Venez; 1997; 48(3):145-53. PubMed ID: 9640674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
